The Dutch antibody services company, today announced that it will continue its collaboration with Sobi™ aimed at the generation of novel monoclonal antibodies against Sobi target(s).
During the new project, ModiQuest will screen their high class in-house phage display libraries, ModiPhage™. Financials details of the collaboration were not disclosed.
“We are delighted that Sobi has selected ModiQuest Research as antibody generation partner,” said Dr. Jos Raats, Managing Director of ModiQuest Research. “We are very much looking forward to build a long-term partnership with Sobi and to apply our unique antibody technology platform in the field of orphan diseases.”